Eyal Schwartzberg

Eyal Schwartzberg is a seasoned professional with extensive experience in healthcare management and academia. Currently serving as Founder and Chairman at ApoWiser Ltd. since January 2021, Schwartzberg also holds roles as a Management Consultant and General Manager at Neopharm Group since March 2019, and as an adjunct associate professor at Long Island University. Schwartzberg has been an Associate Professor at Ben-Gurion University of the Negev since 2004, where leadership of the Master's Program in Community Clinical Pharmacy and Regulatory Management is a key responsibility. Previous positions include Deputy Director General for Research, Development & Innovation at Tel Aviv Medical Center and Head of the Pharmaceutical & Enforcement Divisions at the Israel Ministry of Health. Educational credentials include a PhD in Health System Management from Ben-Gurion University, an MSc in Evidence Based Pharmacotherapy from Aston University, and a BPharm in Pharmacy from Cardiff University.

Location

Petaẖ Tikva, Israel

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


8400 The Health Network

On a mission to drive an Israeli economic growth engine in HealthTech and accelerate global cure, 8400 The Health Network is weaving a network of HealthTech ecosystem leaders, across silos and sectors, who learn together and create gap-closing projects that will propel a thriving HealthTech industry in Israel. The 8400 Fellowship runs annual cohorts of 60 senior Israeli leaders each, for an intensive 17 day program across 7 months. The program’s tailor-made curriculum is creating a continuous platform for breaking silos, peer learning and designing ecosystem growth initiatives. 8400 fellowship graduates join the 8400 Network.


Headquarters

Tel Aviv, Israel

Employees

1-10

Links